Results 131 to 140 of about 7,551 (201)

Predictive value of serum HBV RNA on HBeAg seroconversion in treated chronic hepatitis B patients. [PDF]

Eur J Gastroenterol Hepatol
Liu T, Shi Y, Wu J, Qin L, Qi Y.
europepmc   +1 more source

CTLA-4 haplotype predicts HBsAg and HBcrAg levels and HBeAg seroconversion age in children with chronic HBV infection. [PDF]

JHEP Rep
Wu JF, Tai CS, Chang KC, Chen TW, Chen HL, Ni YH, Hsu HY, Chang MH.   +7 more
europepmc   +1 more source

Fibrosis in chronic viral hepatitis [PDF]

, 2011
Alter, Antonio Craxì, Aranzabal, Bellentani, Benhamou, Benvegnú, Bodsworth, Bonacini, Bortolotti, Bruno, Bruno, Bruno, Bruno, Bruno, Cammà, Chang, Chang, Chang, Chen, Corrao, Corrao, Das, de Jongh, Di Marco, Dienstag, Dienstag, Dunn, D’Amico, D’Souza, Eyster, Fattovich, Fattovich, Fattovich, Fattovich, Feld, Fontana, Fried, Fujiwara, Fung, Fung, George, Graham, Hadziyannis, Heathcote, Hu, Iloeje, Janssen, Kellerman, Kuo, Kweon, Lai, Lampertico, Lau, Lavanchy, Liaw, Liaw, Liaw, Macías, Maida, Maini, Malekzadeh, Mallet, Manensis, Mani, Marcellin, Marcellin, Marcellin, Marcellin, Maylin, Mehta, Miailhes, Mocroft, Monto, Nguyen, Ortiz, Park, Perrillo, Perrillo, Persico, Peters, Peters, Pol, Pontisso, Poynard, Poynard, Poynard, Puoti, Qurishi, Rang, Rincon, Roberts, Roffi, Ruiz-Moreno, Sata, Schiff, Seeff, Serfaty, Shao, Shiratori, Shiratori, Soriano, Soto, Sterling, Sulkowski, Sulkowski, Thorburn, Tong, Tremolada, Tsang, Veldt, Veldt, Vincenza Calvaruso, Walewska-Zielecka, Wang, Weber, Yao, Yao, Yoshida, Zeuzem   +118 more
core   +1 more source

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand [PDF]

, 2014

core   +1 more source

Increasing plasma ADAMTS13 activity is associated with HBeAg seroconversion in chronic hepatitis B patients during 5 years of entecavir treatment. [PDF]

Sci Rep, 2019
Guo R, Xie Y, Yang J, Lu H, Ye P, Jin L, Lin W.   +6 more
europepmc   +1 more source

Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients. [PDF]

World J Gastroenterol, 2019
Luo H, Zhang XX, Cao LH, Tan N, Kang Q, Xi HL, Yu M, Xu XY.   +7 more
europepmc   +1 more source

Quantitative measurement of HBeAg in chronic hepatitis B: A comparison between a radioimmunoassay, a fluorescence ELISA and a chemiluminescence ELISA [PDF]

, 1995
Heijtink, R.A. (Rudolf), Janssen, H.L.A. (Harry), Kerkhof-Los, C. (C.), Kruining, J., Man, R.A. (Robert) de, Schalm, S.W. (Solko), Snobl, J. (J.)   +6 more
core   +1 more source

Elevated pre-treatment IL-18 level is associated with HBeAg seroconversion in HIV-HBV coinfection. [PDF]

Antivir Ther, 2017
Li Y, Xie J, Wang H, Han Y, Wang N, Thio CL, Li T.   +6 more
europepmc   +1 more source

Management Of Patients With Hepatitis B Virus Reactivation Post-DAA Treatment Of Chronic Hepatitis C Virus Infection In HCV-HBV Coinfected Patients With Pretreatment HBeAg Seroconversion And Early Degree Of Hepatic Fibrosis. [PDF]

Infect Drug Resist, 2019
Osman HA, Ghweil AA, Sabry AM, Mahdy RE, Khodeary A.   +4 more
europepmc   +1 more source

A meta-analysis of controlled clinical trials comparing peginterferon-α plus nucleos(t)ide analogs versus peginterferon-α monotherapy for HBsAg clearance or seroconversion in patients with chronic hepatitis B. [PDF]

Front Med (Lausanne)
Zhu S, Yang Z, Wang Y, Cai X, Qin C.
europepmc   +1 more source